UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e484-e491

2021

Link zum Volltext

Verfügbarkeit prüfen

Visualization of subunit interactions and ternary complexes of protein phosphatase 2A in mammalian cells

PloS one, 2014-12, Vol.9 (12), p.e116074-e116074

2014

Link zum Volltext

Verfügbarkeit prüfen

Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells

Molecular pharmacology, 2015-06, Vol.87 (6), p.1006-1012

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

Molecular cancer, 2014-04, Vol.13 (1), p.91-91, Article 91

2014

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx

Molecular cancer research, 2017-08, Vol.15 (8), p.1096-1105

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)

European journal of medicinal chemistry, 2015-04, Vol.94, p.509-516

2015

Link zum Volltext

Verfügbarkeit prüfen

A novel regulator (USP10) of p53: Implications for tumor suppression and therapeutic targeting

Cancer biology & therapy, 2010-04, Vol.9 (8), p.583-584

2010

Link zum Volltext

Verfügbarkeit prüfen

Regulation and Function of the Calcium/Calmodulin-dependent Protein Kinase IV/Protein Serine/Threonine Phosphatase 2A Signaling Complex

The Journal of biological chemistry, 2004-07, Vol.279 (30), p.31708-31716

2004

Link zum Volltext

Verfügbarkeit prüfen

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?

BMJ open, 2013-01, Vol.3 (1), p.e002030

2013

Link zum Volltext

Verfügbarkeit prüfen

FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Clinical cancer research, 2023-02, Vol.29 (3), p.508-512

2023

Link zum Volltext

Verfügbarkeit prüfen

The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity

Mutation research, 2011-03, Vol.708 (1), p.21-27

2011

Link zum Volltext

Verfügbarkeit prüfen

Dual targeting of the androgen receptor and hypoxia-inducible factor-1α pathways to synergistically inhibit castrate-resistant prostate cancer

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.270-270

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of thalidomide on the TGFβ-1-mediated synthesis of testosterone from DHEA in prostate cancer

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.141-141

2012

Link zum Volltext

Verfügbarkeit prüfen

Androgen receptor and HIF-1α interaction in prostate cancer

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.197-197

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2331: Select epidithiodiketopiperazine (ETP) compounds disrupt the HIF-1α/p300 interaction and HIF-mediated transcription

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2331-2331

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2206: Molecular interaction of HIF-1α and the androgen receptor in prostate cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2206-2206

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4535: Thalidomide inhibits the TGFβ-mediated synthesis of testosterone from DHEA in prostate cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4535-4535

2011

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the HIF‐1α/p300 interaction as a means of inhibiting angiogenesis

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Link zum Volltext

Verfügbarkeit prüfen

The Bα and Bδ regulatory subunits of PP2A are necessary for assembly of the CaMKIV·PP2A signaling complex

Biochemical and biophysical research communications, 2009-09, Vol.386 (4), p.582-587

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3095: The molecular, cellular, and physiological consequences of disrupting the HIF-1α interaction

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3095-3095

2011

Link zum Volltext

Verfügbarkeit prüfen

Epidithiodiketopiperazines exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1[alpha]/p300 complex in a preclinical model of prostate cancer

Molecular cancer, 2014-04, Vol.13

2014

Link zum Volltext

Verfügbarkeit prüfen

The Balpha and Bdelta regulatory subunits of PP2A are necessary for assembly of the CaMKIV.PP2A signaling complex

Biochemical and biophysical research communications, 2009-09, Vol.386 (4), p.582-587

2009

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the CaMKIV•PP2A signaling module

Reece, Kelie M

2010

Link zum Volltext
ProQuest

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)
Dissertationen
(1)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Humans
(9)
Oncology
(6)
Signal Transduction
(6)
Animals
(3)
Antineoplastic Agents - Pharmacology
(3)
Cancer
(3)
Cell Line
(3)
Hypoxia
(3)
Hypoxia-Inducible Factor 1, Alpha Subunit - Metabolism
(3)
Male
(3)
Mutation
(3)
Phosphorylation
(3)
Angiogenesis
(2)
Biochemistry & Molecular Biology
(2)
Cancer Research
(2)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(2)
Carcinoma, Non-Small-Cell Lung - Genetics
(2)
Cell Line, Tumor
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma

Visualization of subunit interactions and ternary complexes of protein phosphatase 2A in mammalian cells

Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx

Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)

A novel regulator (USP10) of p53: Implications for tumor suppression and therapeutic targeting

Regulation and Function of the Calcium/Calmodulin-dependent Protein Kinase IV/Protein Serine/Threonine Phosphatase 2A Signaling Complex

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?

FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations

FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity

Dual targeting of the androgen receptor and hypoxia-inducible factor-1α pathways to synergistically inhibit castrate-resistant prostate cancer

Effect of thalidomide on the TGFβ-1-mediated synthesis of testosterone from DHEA in prostate cancer

Androgen receptor and HIF-1α interaction in prostate cancer

Abstract 2331: Select epidithiodiketopiperazine (ETP) compounds disrupt the HIF-1α/p300 interaction and HIF-mediated transcription

Abstract 2206: Molecular interaction of HIF-1α and the androgen receptor in prostate cancer

Abstract 4535: Thalidomide inhibits the TGFβ-mediated synthesis of testosterone from DHEA in prostate cancer

Disruption of the HIF‐1α/p300 interaction as a means of inhibiting angiogenesis

The Bα and Bδ regulatory subunits of PP2A are necessary for assembly of the CaMKIV·PP2A signaling complex

Abstract 3095: The molecular, cellular, and physiological consequences of disrupting the HIF-1α interaction

Epidithiodiketopiperazines exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1[alpha]/p300 complex in a preclinical model of prostate cancer

The Balpha and Bdelta regulatory subunits of PP2A are necessary for assembly of the CaMKIV.PP2A signaling complex

Regulation of the CaMKIV•PP2A signaling module

Suchergebnisse filtern